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Florfenicol (FLO) is a third-generation veterinary antibiotic with a high residue detection rate in food, which
cause the toxicity of FLO even at low doses, receiving notable attention. The impact of FLO exposure during early
life on health and gut microbiota is still unclear. Here, the effects of FLO exposure on toxicity, gut microbiota,
drug resistance genes, and the fecal metabolome during early life were investigated in suckling Sprague-Dawley
(SD) rats. The results showed that FLO exposure during early life significantly increased the body weight, and
WBC and LY levels in the blood, induced inflammation in the liver and intestines. FLO had a dose-dependent
effect on the alpha and beta diversity of the gut microbiota, increasing the ratio of Firmicutes to Bacteroides
and the abundance of some pathogenic bacteria, and changing the abundance of bacteria related to energy
metabolism and inflammation, also promoted the enrichment of drug resistance genes. The fecal metabolome
also demonstrated the effect of FLO exposure on metabolic pathways related to energy metabolism and
inflammation. In conclusion, this research shows that FLO exposure during early life can lead to excessive weight
gain, an inflammatory response, gut microbiota imbalance, the enrichment of drug resistance genes, and effects
on related metabolic pathways.
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1. Introduction
Florfenicol (FLO) is a synthetic derivative of chloramphenicol, which
is primarily used to treat most gram-positive and gram-negative bacteria
infections
in
animals(Lis
et
al.,
2011),
especially
chloramphenicol-ethylsulfonamycin
broad-spectrum
resistant
gram-negative bacteria infections, as FLO has a better curative effect and
an improved ability to inactivate bacteria relative to chloramphenicol
(Varma et al., 2010). As a third-generation animal-specific amido
alcohol antibiotic, FLO uses sulfomethyl (-SO2CH3) to replace the nitro
group (-NO2) in chloramphenicol. Therefore, FLO does not cause
aplastic anemia in the body or cause mutagenic, carcinogenic or tera
togenic effects, which makes FLO one of the most widely used antibiotics
in the aquaculture industry(M et al., 1983). However, studies have
shown that FLO still has certain acute and chronic toxicity and immu
notoxicity(Bretzlaff et al., 2010). Most countries have stipulated the

maximum residue limit (MRL) for FLO in foods of animal origin (MRL
200–3000 mg/kg). Due to the higher MRL, FLO has become one of the
veterinary drugs with the highest residue detection rate in foods of an
imal origin (Wang et al., 2016).
The gut microbiota is closely related to fat metabolism and energy
homeostasis, and is also influenced by other factors such as dietary
habits, cesarean section and breastfeeding (Mayorga et al., 2017; Pihl
et al., 2016). Among these, antibiotic exposure is a potential threat.
Early life is a critical period that gut microbiota colonize and establish.
Exposure to antibiotics during this period may not only cause toxic
damage but may also interfere with the normal gut microbiota, leading
to a series of metabolic diseases(Altobelli et al., 2003). Previous studies
have shown that antibiotics, such as vancomycin, penicillin and chlor
tetracycline, can alter the composition of gut microbiota, affecting the
metabolism of bile acids, thereby increasing fat accumulation(Ilseung
et al., 2012). Epidemiological studies have also reported a positive
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association between antibiotic use in children and childhood obesity
(Antti et al., 2015; Yallapragada et al., 2015). Monitoring of antibiotic
levels in urine revealed that the rate of obesity in school-aged children
was associated with levels of antibiotics such as florfenicol and metho
trexate(Wang et al., 2016). Since FLO is widely present in foods of an
imal origin although its residual amount is often lower than the MRL, the
impacts of FLO exposure during early life on the gut microbiota and
metabolism are still unclear and worthy of attention considering the
sensitivity experienced during early life,
In this study, different exposure doses of FLO (2, 20, 200, 2000 μg/kg
BW) were administered by gavage for 15 days in suckling SD rats.
Toxicological changes in hematology, serum biochemistry and histo
pathology were evaluated. High-throughput sequencing of 16S rRNA
was used to clarify the changes in the gut microbiota after FLO exposure.
Changes in resistance genes in the gut microbiota were detected using
qPCR. The changes in fecal metabolomes after FLO exposure were
characterized by UPLC-Q/TOF. This research provides knowledge
respecting the potential risks of low-level FLO exposure during early life.
These information may be helpful for further studies on the dietary
intake of FLO residue in infants and young children.

2.3. Histological analysis
The liver, spleen, kidney, and duodenal tissue of rat pups were fixed
with 10% neutral buffered formalin and processed in accordance with
standard protocols (dehydration with gradient alcohol, transparent tis
sue with xylene, impregnation with wax, paraffin embedding, block
sections, patches, and baked slices) after 48 h, were stained with he
matoxylin-eosin (HE). Histopathology was examined using a microscope
(E200, Nikon, Japan).
2.4. Analysis of gut microbiota
Stool samples of suckling SD rats were snap-frozen in liquid nitrogen.
Metagenomic DNA was isolated using the TIANamp Stool DNA Kit
(Tiangen Biotech, Beijing, China). PCR was performed for amplifying
the V3-V4 region of the 16S rRNA gene by the forward primer 5′ ACTCCTACGGGAGGCAGCAG-3′ and the reverse primer 5′ - GGAC
TACHVGGGTWTCTAAT-3′ . The PCR products were high-throughput
sequenced on an Illumina MiSeq platform (Illumina, CA, USA) by
Majorbio Co. Ltd. (Shanghai, China).
The alpha and beta diversities were analyzed to identify the species
diversity on the online Majorbio I-Sanger Cloud Platform (www. isanger.com). The Ace, Sobs, Simpson, Shannon, and Chao1 indexes are
used to characterize the biodiversity richness. The distance matrix was
visualized by utilizing principal coordinate analyses (PCoA) based on
beta diversity. The important difference species are screened out using
linear discriminant analysis effect size (LEfSe) analysis tool by per
forming cladogram construction and linear discriminant analysis (LDA).

2. Material and methods
2.1. Animals experiment
Suckling SD rats (birth 48 h) from 6 mother rats were purchased from
Chengdu Dashuo Experimental Animal Co., Ltd. (Chengdu, China). The
pup rats were kept in a barrier-class animal room of 22 ± 2 ℃ and 55～
75% relative humidity in a 12/12 h light/dark cycle with mother rats.
Mother rats were fed standard rat food (AIN-93 G) and sterile water. The
pup rats from the same mother rat were randomly divided into 5 groups
(each group included 8–12 rat pups from 6 different mother rats, and
randomly included males and females). On the 7th day after birth, the
pup rats were given respectively different doses of FLO by oral gavage
for 15 days (0, 2, 20, 200 or 2000 μg/kg BW FLO in 0.9% saline). The
dosage of FLO was determined according to the residual amount of FLO
in food and the ADI value. After weaning, the pup rats were fed with
standard rat food and sterile water. Fecal samples of pup rats were
collected every 5 days from the day after the end of FLO exposure and
stored at − 80 ℃ until analysis. On the 20th day after the end of FLO
exposure (aged 42 days after birth), the pup rats were sacrificed by CO2
anesthesia. The liver, spleen, kidney, duodenums, and blood from the
heart were collected for experiments.
All experimental animal procedures were in accordance with the
relevant guidelines and principles and approved by the Experimental
Animal Ethics Committee of Chengdu Medical College.

2.5. Real-time quantitative PCR analysis
Total DNA of the intestinal flora was extracted from the fecal samples
by a TIANamp Stool DNA Kit (Tiagen Biochemical Technology Co., Ltd.,
Beijing, China). According to the requirements of the International
Standard for Real-time Fluorescent Quantitative PCR (MIQE), specific
primers were designed (Supplementary Table 1). The different resis
tance genes of FLO in the intestinal flora (such as floR, fexA, and Cfr)
were detected using real-time quantitative PCR detection system
(CFX96™, Bio-Rad, Hercules, USA) with Talent Fluorescence Quanti
tative Assay Kit (Tiagen Biochemical Technology Co., Ltd., Beijing,
China). The PCR procedure was a three-step method: 94 ℃ denaturation
for 3 min, followed by 40 cycles of 94 ℃ denaturation for 5 s, annealing
at a given temperature for 10 s, extension at 72 ℃ for 15 s, and plate
reading at 72 ℃ for 5 s. After the amplification cycle, the solution curve
of the RCR product was detected to eliminate the interference of
nonspecific amplification. A negative control was set during the process
of PCR amplification to eliminate contamination. The 16S rRNA gene
was used as an internal control. The changes in the abundance of
resistance genes were analyzed by the 2-ΔΔCt method.

2.2. Analyses of blood and serum biochemical
Rat heart whole-blood was collected respectively in an anticoagulant
blood collection tube with EDTA for hematology analysis and in an
EDTA-free blood collection tube and centrifuged at 3000 rpm for 10 min
for serum biochemical analysis.
The white blood leucocyte count (WBC), red blood cell count (RBC),
hemoglobin (HGB), platelet count (PLT), neutrophil count (NE), average
red blood cell volume (MCV), lymphocyte count (LY), mean hemoglobin
(MCH), red blood cells deposited (HCT), and mean hemoglobin con
centration (MCHC) were measured using a blood analyzer (ADVIA 2120,
Siemens, Germany). Glutamate transpeptidase (GGT), alkaline phos
phatase (ALP),serum alanine aminotransferase (ALT), albumin (ALB),
globulin (GLB), total protein (TP), white ball ratio (A/G), aspartate
aminotransferase (AST), urea, total cholesterol (CHOL), creatinine, tri
glycerides (TG) were analyzed by a biochemical analyzer (AU2700,
Olympus, Japan).

2.6. UPLC-Q-TOF analysis of fecal metabolites
The metabolic compounds in fecal samples were extracted using
ultrapure water, methanol and acetonitrile, and were detected using
UPLC-Q-TOF (The LC30 UPLC system (Shimazu, Japan)) connected with
an high-resolution mass spectrometry system in the positive ion mode
(X500R, AB Sciex, CA, USA) as previously described(Dai et al., 2020).
Mass spectral data were processed for peak identification, peak align
ment, characteristic peak extraction using Mark-View softwar
(ABSCIEX, CA, USA). The baseline calibration, noise reduction and
singularity elimination were performed according to QC samples. Then,
the data were analyzed on an online MetaboAnalyst platform (version
5.0, www. metaboanalyst.ca)(Pang et al., 2021). The potential bio
markers related to FLO exposure were screened in accordance with the
loading plot, the S-plot, and the variable importance in the project (VIP)
value (VIP > 1.0). The key metabolites screened out were identified by
2
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searching available mass spectrometry results, such as the MassBank of
North America (MoNA, massbank.us), Human Metabolome Database
(HMDB, www.hmdb.ca), and Metabolite and Tandem MS Database
(METLIN, Metlin.scripps.edu). The pathways of the metabolites were
annotated by the Kyoto Encyclopedia of Genes and Genomes (KEGG,
www.kegg.com).
2.7. Statistical analysis
All data were expressed as the mean±S.E.M. The statistical analysis
was carried out by Student’s t-test for the comparison between two
groups, or ANOVA followed by Duncan’s shortest significant range test
for the comparison between multiple groups using SPSS 22 software
(IBM, chicago).
3. Result
3.1. Clinical observations
Repeated oral exposure to suckling SD rats with different doses of
FLO for 15 days did not cause death. None of the clinical signs such as
mental state, behavior, daily activities, or appearance of the exposure
groups showed treatment-related changes, compared with the control
group. In addition, the body weight growth rate of the 200 and 2000 μg/
kg BW FLO exposure groups was significantly higher than that of the
control group and showed a dose-dependent effect (Fig. 1). This suggests
that FLO exposure during early life may affect the body weight of
suckling SD rats.
3.2. Hematology
The effects of FLO exposure on hematological indexes are shown in
Supplementary Table 2. The WBC and LY were significantly increased in
the 20, 200 and 2000 μg/kg BW FLO exposure groups, indicating that
FLO exposure may be the cause of an inflammatory response. Although
there were significant changes in HGB and HCT there was no strict dosedependent trend, which implies that these changes may not be related to
exposure to FLO during early life.
3.3. Blood chemistry

Fig. 1. Changes of body weight (A) and average daily weight gain (B) in
suckling SD rats after FLO exposure during early life. Data were presented as the
mean ± SEM (n = 5). # P < 0.05 (FLO 2000 μg/kg BW vs. Control), * P < 0.05
(FLO 200 μg/kg BW vs. Control), ^ P < 0.05 (FLO 20 μg/kg BW vs. Control), $
P < 0.05 (FLO 2 μg/kg BW vs. Control). Bars with the different letters represent
a significant difference between groups (P < 0.05).

The blood biochemical indexes of the suckling SD rats after FLO
exposure during early life are showed in Supplementary Table 3. The
results demonstrated that most of the blood biochemical indexes were
not significantly different. Although the creatinine after FLO exposure
during early life was significantly increased, while the CHOL was
significantly decreased, there was no strict dose-dependent trend.
However, the AST was significantly increased in the 2–2000 μg/kg BW
FLO exposure groups, suggesting that FLO exposure may cause liver
damage or inflammation.

3.5. Effects of FLO exposure during early life on the gut microbiota
A total of 1772,859 usable pyrophosphate sequences were obtained
from 45 samples with an average sequence length of 443.86 bp. After
the above obtained sequences were optimized by discarding the
chimeric sequences and the unqualified sequences using Usearch soft
ware, 1010,745 sequences were obtained. The 22,461 valid sequences
were obtained for each sample by random extraction to a uniform se
quences amount according to the minimum sequences number in sam
ples. The above valid sequences were clustered into 349 operational
taxonomic units (OTU) by QIIME software with a 97% similarity level.
Rarefaction curves based on the Shannon, Sob, and Simpson indexes
indicated that the amount of sequencing data was large enough to reflect
the biological diversity (Supplementary Fig. 1).
The results of alpha diversity analysis based on the number of OTU
sequences of each sample are shown in Table 1. The ANOVA of alpha
diversity indexes showed that different FLO exposure concentrations

3.4. Histopathology
No abnormalities were observed on the histopathology of the suck
ling SD rats. The organ index for all groups did not show a dosedependent relationship (data not shown). However a series of
treatment-related pathological changes in the liver tissue and intestinal
tissue appeared in the FLO exposure groups (Fig. 2), including nonobvious liver lobes, swelling and degeneration of liver cells around
veins, inflammatory lesions, slight fat degradation, and spot necrosis in
liver tissue, as well as degeneration and necrosis of intestinal mucosal
epithelial cells and inflammatory cell infiltration in the intestinal
mucosal layer, compared with the control group.
3
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Fig. 2. Changes of FLO exposure on of histo
pathology in liver tissue and intestinal tissue.
(A) Normal liver in the control group (×200,
HE); (B) Vacuolar degeneration of hepatic cells
in the 2000 μg/kg FLO exposure group (×200,
HE); (C) Hepatocyte swelling and inflammatory
lesions in the 2000 μg/kg FLO exposure group;
(D) Point necrosis and mild fat degradation in
the 200 μg/kg FLO exposure group; (E) Normal
intestinal tissue in the control group (×400,
HE); (F) Mucosal epithelial cell infiltration in
the 2000 μg/kg FLO exposure group (×400,
HE).

Table 1
Effects of FLO exposure on diversity index of gut microbiota in suckling SD rats.
FLO exposure concentration (μg/kg BW)
Control
2
20
200
2000
Control
2
20
200
2000
Control
2
20
200
2000

Withdrawal period (day)
0

10

20

Sobs

Shannon

Simpson

ACE

Chao 1

225 ± 18.58
206.33 ± 6.67
222 ± 10.02
244 ± 4.04
212 ± 5.13
277 ± 13.89
259 ± 47.27
288.67 ± 24.66
269 ± 19.66
233.33 ± 13.45
238.33 ± 8.69
267.67 ± 14.77
267.67 ± 22.81
335 ± 18.58
321.67 ± 19.91

3.21 ± 0.12
3.15 ± 0.18
3.19 ± 0.14
3.66 ± 0.06
3.16 ± 0.15
3.17 ± 0.12
3.64 ± 0.29
3.61 ± 0.44
3.46 ± 0.22
2.78 ± 0.34
2.83 ± 0.31
3.34 ± 0.35
3.36 ± 0.26
3.57 ± 0.14
3.25 ± 0.35

0.09 ± 0.01
0.1 ± 0.02
0.11 ± 0.02
0.06 ± 0.01
0.11 ± 0.02
0.12 ± 0.01
0.06 ± 0.02
0.09 ± 0.05
0.08 ± 0.02
0.21 ± 0.07
0.16 ± 0.04
0.1 ± 0.04
0.09 ± 0.02
0.08 ± 0.01
0.18 ± 0.06

268.5 ± 21.49
248.34 ± 10.94
257.13 ± 9.47
281.93 ± 9.13
256.1 ± 2.82
329.6 ± 9.71
288.93 ± 49.7
321.49 ± 21.12
324.38 ± 15.27
261.96 ± 17.96
284.71 ± 18.83
315.77 ± 16.89
317.6 ± 29.17
378.82 ± 12.66
356.33 ± 18.09

275.08 ± 19.9
252.16 ± 12.93
255.86 ± 9.96
286.97 ± 11.15
260.34 ± 0.99
340.67 ± 9.22
289.77 ± 51.19
318.99 ± 21.6
327.47 ± 23.9
265.95 ± 17.86
292.98 ± 15.61
324.47 ± 12.23
330.04 ± 35.52
382.42 ± 15.48
369.38 ± 21.78

Data were presented as mean ± SEM (n = 3).

significantly affected the community diversity indexes (such as Simpson
and Shannon), while the withdrawal period after FLO exposure to
community richness indexes (such as Chao1, Sobs and Ace) had a sig
nificant impact (Supplementary Table 4). Multiple comparisons of FLO
exposure concentration using Duncan’s method revealed that only

20 μg/kg BW FLO exposure can significantly change the Shannon and
Simpson indexes (Supplementary Fig. 2A, B). This indicates that lowlevel FLO exposure during early life has a significant impact on the di
versity and homogeneity of the gut microbiota. Multiple comparisons of
the withdrawal period using Duncan’s method showed that the Sobs,
4
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Ace, and Chao1 indexes of the withdrawal period at 10 and 20 days
significantly increased compared with that of withdrawal period at
0 days, and there was no significant difference in the Sobs, Ace, and
Chao1 indexes of withdrawal period at 10 and 20 days (Supplementary
Fig. 2C–E). This implies that the number of species in the gut microbiota
of suckling SD rats increased rapidly and stabilized after FLO exposure
and withdrawal for 10 days. Therefore, the sample data from the
withdrawal period 10 days after FLO exposure were used for beta di
versity analysis (P < 0.001, ANOSIM test on binary Euclidean distances)
to reflect the differences in microbial communities between sample
groups. The two-dimensional PCoA score plot displayed a distinct sep
aration pattern and indicated that the gut microbiota has a structural
difference between FLO exposure groups and the control groups
(Fig. 3C).
The species composition of the gut microbiota was determined by
taxonomic assignment using the Ribosomal Database Project (RDP)
classifier. The 668 OTUs were classified into 14 phyla, 24 classes, 33
orders, 58 families, 154 genera, and 274 species. At the phylum level,
Firmicutes and Bacteroides were the dominant phyla, accounting for more
than 90% of the gut microbiota (Fig. 3A), and the ratio of Firmicutes and
Bacteroide increased with increasing FLO exposure concentration (Sup
plementary Fig. 3F). At the family level, Lactobacillaceae and Bacter
oidales_S24_7_group were the two most abundant Bacteroidetes families

(Fig. 3B). However, the abundances of only 4 families were significantly
impacted with a dose-dependent effect under FLO exposure (ANOVA,
P < 0.05), such as Bifidobacteriaceae, Prevotellaceae, Bacter
oidales_S24–7_group, and Erysipelotrichaceae. The taxonomy cladograms
generated by LEfSe analysis showed that the predominant different
species of FLO exposure similar to the above analysis (Fig. 3D). The
relative abundance of biomarkers at the genus level and FLO exposure
concentration showed a dose-dependent effect (Supplementary Fig. 3).
The genera whose abundance decreased with increasing FLO exposure
concentration included Staphylococcus, Chlamydia, Jeotgalicoccus, Pre
votellac_9, Prevotellaceae_UCG_001, Christensenellaceae_R_7_group, and
Corynebacterium_1. The genera whose abundance increased with
increasing FLO exposure concentration included Intestinimona, Rumino
coccaceae_UCG_013, norank_f__Lachnospiraceae, and Ruminiclostridium.
However, 2000 μg/kg BW FLO exposure still significantly reduced the
abundance of these genera. In addition, the abundances of Adlercreutzia,
Parasutterella,
norank_f__Ruminococcaceae,
DesuLfovibrio,
nor
ank_f__Bacteroidales_S24_7_group, AllobacμLum, Bifidobacterium, Tyzzer
ella, and norank_f__Erysipelotrichaceae increased significantly after only
2 μg/kg BW FLO exposure, but with the increase of FLO exposure con
centration, their abundances showed a gradual decreasing trend,
compared with the control group.

Fig. 3. Effects of FLO exposure on the gut microbiota in suckling SD rats. Changes of relative abundance on phylum (A) and family (B) level. PCoA two-dimensional
score plots based on gut microbiota OTU data (C). Taxonomic cladogram from phylum to genus based on the LEfSe analysis (D).
5
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3.6. Effect of FLO exposure during early life on drug resistance genes

3.7. Effect of FLO exposure during early life on fecal metabonomic

Real-time fluorescent quantitative PCR was preformed to understand
the effect of FLO exposure during early life on drug resistance genes in
the gut microbiota of suckling SD rats. The changes in the abundance of
the typical florfenicol resistance genes floR, fexA and cfr in the gut
microbiota are shown in Fig. 4. The results showed that the abundance
of the resistance genes floR and fexA increased significantly in samples
of withdrawn 0 days after FLO exposure, and fexA was more sensitive to
FLO exposure, while the abundance of cfr did not significantly change.
However, in the sample of withdrawal period at 10 days, FLO exposure
caused a significant increase in the abundance of floR, fexA, and cfr,
with a dose-dependent effect. This indicates that the proportion of
resistant bacteria, and the relative abundance of resistance genes
increased significantly after FLO exposure during early life. In addition,
the difference in the relative abundance of drug resistance genes in
samples with different withdrawal periods after FLO exposure also
implied that the change in the proportion of bacteria containing drug
resistance genes in the gut microbiota reflects a time course of
enrichment.

To understand the effects of FLO exposure during early life on fecal
metabolites, fecal samples from the withdrawal period at 10 days after
FLO exposure were measured by UPLC-QTOF. The 253 detectable peaks
were observed. To distinguish the differences in fecal metabolites, the
PLS-DA model, as a supervised multivariate statistical method, was used
to analyze the multidimensional metabolite abundance scale. The crossvalidation results suggested that the model had good predictive ability
and was not overfitted (Q2 = 0.69 and R2Y= 0.99). The PLS-DA score
plots showed that the control group was clearly distinguished from the
20 μg/kg BW FLO exposure group, closed to the 2 μg/kg BW FLO
exposure group, and all groups were mainly distributed in different
quadrants (Fig. 5). These results indicate that a lower dose of FLO
exposure can also cause significant differences in the fecal metabolome
of SD rats.
To further explore the impact of FLO exposure on metabolism, the
hierarchical cluster heatmap was drawn in accordance with the abun
dance of the metabolites (Supplementary Fig. 4). The samples from the
FLO 20 μg/kg BW exposure groups clustered into different trees, how
ever, the 2 μg/kg BW FLO exposure group and control group were mixed
with each other at a closer distance. This indicates that 20 μg/kg BW
FLO exposure during early life has a significantly higher impact on fecal
metabolites than the effect of 2 μg/kg BW FLO exposure. A total of 52
metabolites that played important roles in distinguishing whether FLO
exposure were screened in accordance with the VIP value (VIP > 1).
Seventeen metabolites as potential biomarkers of FLO exposure were
identified by comparing the exact mass and MS/MS spectrum from the
metabolomics databases (METLIN HMDB, and MoNA). The information
of 17 metabolites including m/z value, molecular formula, exact mass,
KEGG ID, compound name, VIP value and change trend are shown in
Table 2, and most of them were significantly changed after FLO exposure
(P < 0.05). The metabolic pathways of the potential biomarkers were
clarified by metabolite enrichment analysis using the KEGG database.
The results showed that FLO exposure during the early life had a sig
nificant effect on phenylalanine and tyrosine metabolism (phenylala
nine, L-tyrosine), the urea cycle, and aspartic acid metabolism (Lglutamate amino acid, citrulline), niacin and niacinamide metabolism
(L-glutamic acid, niacin) in suckling SD rats.
4. Discussion
As a derivative of chloramphenicol, FLO has been widely used in
veterinary medicine because of its safer and broad-spectrum properties
(Wang et al., 2016). The current study found that the LD50 values of FLO

Fig. 4. Relative abundances of the resistance genes floR, fexA and cfr by qPCR
at 0 days (A) and 10 days (B) after the oral administration of florfenicol. All
data are presented as the mean ± SEM (n = 3). Bars with the different letters
represent a significant difference between groups (P < 0.05).

Fig. 5. PLS-DA two-dimensional score plot based on fecal metabo
lites (n = 6–8).
6
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Table 2
Effects of FLO exposure on the biomarkers in fecal samples.
M/Z

Excat mass (Da)

Elemental composition

Postulated identity

KEGG ID

VIP values

FLO 20 μg/kg BW vs. Control

176.1041
124.0383
162.0536
159.0757
359.2861
136.0743
182.0808
112.0059
137.0452
162.0553
148.0600
222.0968
391.2838
220.1175
166.0855
130.0857
138.0537

175.0957
123.0320
161.0476
158.0691
324.0777
135.1047
181.0739
111.0796
136.0385
161.0477
147.0532
221.0899
390.277
219.1107
165.079
129.079
137.0477

C6H13N3O3
C6H5NO2
C9H7NO2
C6H10N2O3
C17H13ClN4O
C9H13N
C9H11NO3
C5H9N3
C5H4N4O
C9H7NO2
C5H9NO4
C8H15NO6
C24H38O4
C9H17NO5
C9H11NO2
C6H11NO2
C7H7NO2

Citrulline
Nicotinic acid
2-Indolecarboxylic acid
4-Methylene-L-glutamine
Alpha-hydroxyalprazolam
Amphetamine
L-Tyrosine
Histamine
Hypoxanthine
Indole-3-carboxylic acid
L-Glutaminic acid
N-Acetylgalactosamine
Nutriacholic acid
Pantothenic acid
Phenylalanine
Pipecolic acid
Trigonelline

C00327
C00253
–
C01109

1.8879
2.8903
3.4631
1.9892
1.4438
2.4287
1.528
1.2023
2.7475
3.0481
1.1103
1.8343
1.983
1.1684
1.1385
1.1736
1.2529

↑
↑
↑
↑
↓
↑
↑
↓
↑
↑
↓
↓
↓
↑
—
—
↓

–
C00082
C00388
C00262
C19837
C00025
C01074
–
C00864
C00079
C00408
C01004

(Selected ion [M + H] +).↑indicates significantly increased at P < 0.05; ↓indicates significantly decreased at P < 0.05; —indicates no statistical significance.

are as high as 2000–5000 mg/kg with acute exposure, and almost no
acute toxicity(Nahler, 2009). Mice showed no significant effect on body
weight or various tissues and organs after 500 mg/kg BW FLO exposure
by gavage(Hu et al., 2016). In this study, doses of FLO exposure by
gavage were determined based on the residue range of FLO in foods of
animal origin. Even after 20 days of FLO exposure during early life,
suckling SD rats did not show changes related to FLO exposure in terms
of clinical symptoms such as behavior, mental state, food and water
consumption, daily activities or appearance. At the same time, there
were no obvious abnormalities in the main organs, such as the heart,
liver, spleen, lung, and kidney, which is consistent with previous
research(Hu et al., 2016). However, some studies reported that FLO may
affect RBC and PLT production, and the underlying mechanism may
involve impairment of bone marrow hematopoiesis during FLO treat
ment, resulting in moderate atrophy of the hematopoietic lineage, which
is partially replaced by adipocytes(Hassanin et al., 2014). Since no sig
nificant inflammation or necrosis was observed, moderate atrophy of the
hematopoietic lineage was mainly attributable to drug-induced
apoptosis(Hu et al., 2014). Abnormal reductions in RBCs and PLTs
were not observed in our study, which may be due to the low dose of FLO
exposure in this study.
It is widely believed that FLO has a strong immunosuppressive effect,
decreasing leukocyte and lymphocyte concentrations and inhibiting
lymphocyte function. In addition, the phagocytic capacity of neutrophils
and macrophages may be inhibited by FLO. However, this study found
that the WBCs and LYs were significantly increased in the FLO exposure
groups (P < 0.05). Combined with the inflammatory lesions and
lymphocyte infiltration in the liver and intestinal tissues, we found that
low-dose FLO exposure during early life may cause low-level inflam
matory reactions. Some studies have shown that exposure to antibiotics
during early life such as penicillin and erythromycin may disrupt in
testinal microbes and inhibit the innate immune response of the ileum,
cause intestinal disorders and damage the integrity of the intestine. This
process often leads to the release of intestinal gram-negative bacterial
endotoxins into the blood, which in turn stimulates the inflammatory
response mediated by Toll-like receptor 4 (TLR4), ultimately leading to
the immune response and low-level inflammation(Jin et al., 2016), and
childhood anaerobic antibiotic exposure is also closely related to in
flammatory bowel disease(Örtqvist et al., 2019).
There is no doubt that antibiotics play a critical role in improving
human health, but their widespread use has had some unintended
consequences, such as the potential to promote growth(Högberg et al.,
2014). In the 1950s, subtherapeutic doses of antibiotics were found to
accelerate weight gain in livestock(Lassiter, 1955), and a similar result
was also observed in this study. The mechanism may involve the direct
action of antibiotics on the intestine and the link between alterations in

gut microbiota and changes in human metabolism (Tremaroli and Bã
¤Ckhed, 2012; Turnbaugh et al., 2009). A recent study found that an
tibiotics increased the amount of body fat in mice and were associated
with changes in the composition of the gut microbiota(Ilseung et al.,
2012). Antibiotics not only increase energy intake and regulate satiety
through hormonal changes, but also affect the expression of genes
related to the conversion of carbohydrates to short-chain fatty acids
(SCFAs) in microorganisms (Turnbaugh et al., 2006). The gut microbiota
in infants is more susceptible to interference (Vael et al., 2011). Several
recent studies on children have shown that antibiotic exposure during
early life can lead to weight gain and aggravate the risk of obesity
(Murphy et al., 2014). Changes in the gut microbiota are related to
obesity and metabolic disorders (Vanessa, 2013), in which the F/B ratio
is a biomarker for assessing lipid metabolism(Cani et al., 2009). The
increase in the F/B ratio and changes in several bacterial species can
promote obesity development in obese mouse models of diet-induced or
genetic phenotypes(Cani et al., 2008), which is consistent with the ob
servations in this study.
In addition, the abundance and composition of the gut microbiota
also produced significant changes after FLO exposure during early life.
Among the bacterial genera whose abundance was significantly reduced
after FLO exposure, Christensenellaceae_R_7_group is believed to be
related to effective obesity intervention (Liu et al., 2019b) and regula
tion of abnormal glucose tolerance (Gong et al., 2020), and can improve
the ability of the host to metabolize energy and substances(Sun et al.,
2019). Prevotellaceae_UCG_001 and Prevotellac_9, members of Pre
votellaceae, are rich in enzymes that degrade cellulose and xylan (De
Filippo et al., 2010). They can influence the body’s energy expenditure
(Carvalho and Saad, 2013) by regulating the protein kinase pathway
(AMPK) associated with energy metabolic homeostasis and can produce
SCFAs and degrade dietary fiber by regulating the protein kinase
pathway (AMPK) related to the balance of energy metabolism(Song
et al., 2019; Xiao et al., 2020), which affects energy consumption and
reduces intestinal inflammation(Scheppach and Weiler, 2004).
However, the abundance changes of other bacterial genera showed
that the proliferation of these bacterial genera was stimulated in the lowdose FLO exposure groups, and the growth of these bacterial genera was
inhibited in the high-dose FLO exposure group. This suggests that lowdose FLO exposure on these bacteria may produce hormesis effects
(Rial et al., 2011) and has a greater impact on the gut microbiota.
Among these bacteria, Ruminococcaceae_UCG_013, Intestinimonas,
Ruminiclostridium, and norank_f__Ruminococcaceae are members of
Ruminococcaceae. Some research proves that the metabolic process of
Ruminococcaceae can produce an inflammatory polysaccharide and
cause inflammatory bowel disease (Henke et al., 2019; Ma et al., 2020).
The abundance of Ruminococcaceae is proportional to gastrointestinal
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symptoms such as chronic constipation and diarrhea (Dan et al., 2020),
and also is positively associated with immune A protein nephropathy
(IgAN) (De Angelis et al., 2014). Intestinimonas has also been found that
can produce butyrate using lysine, which is closely related to obesity and
intestinal inflammation(Song et al., 2020). Norank_f_Lachnospiraceae
and Tyzzerella come from Lachnospiraceae. Lachnospiraceae is associated
with metabolic diseases such as obesity and diabetes(Li et al., 2019) and
can affect blood glucose regulation by causing pancreatic β-cell
dysfunction in sterile mice(Kameyama and Itoh, 2014). Some studies
have also shown that a high abundance of norank_f_Lachnospiraceae has
an inhibitory effect on fatty acid metabolism(Yu et al., 2020). Tyzzerella
is also a potentially pathogenic bacterium(Fomenky et al., 2018) whose
abundance is susceptible to dietary patterns and is high in populations
with poorly structured diets(Liu et al., 2019a). Norank_f_Erysipelo
trichaceae, AllobacuLum belongs to the Erysipelotrichaceae family, which
is believed to be related to colon inflammation. For example Erysipelo
trichaceae has a higher abundance in the gut microbiota of colitis mouse
model(Chen et al., 2017). Desulfovibrio is a sulfate-reducing bacterium
that can produce toxins and destroy the mucosal barrier and is closely
related to inflammation(Zhang et al., 2010). In short, significant
changes in the abundance of the abovementioned bacterial genera may
be among the reasons for the higher weight gain and inflammation in the
suckling SD rats after FLO exposure.
In the gut microbiota, the survival and impact of pathogens and
conditional pathogens depend on resistance to antibiotics (Agarwal and
Nair, 2013). Antibiotic resistance of bacteria can be obtained through
gene transfer of resistance gene genetic elements, and antibiotic resis
tance genes are closely related to transposons, plasmids and integrons
(Stokes and Gillings, 2011). For example, the tet gene encoding the
tetracycline efflux protein is normally found in plasmids in an aqueous
environment(Chopra and Roberts, 2001). This study also found that
florfenicol resistance genes can be enriched in the gut microbiota and
released into the environment with feces. The release of the resistance
genes poses a potential threat to public health and deserves further
attention.
Phenylalanine, as one of the metabolites affected by FLO exposure,
can be converted to tyrosine in the liver. Tyrosine is the raw material for
the synthesis of catecholamines and thyroid hormones. (Zhang et al.,
2014). This process is also related to energy metabolism in the liver and
brain (Ramos et al., 2013). Excessive levels of tyrosine in the FLO
exposure groups not only led to a decline in the body’s energy meta
bolism (de Andrade et al., 2011) and increased body weight but also
caused neurological dysfunction in pup SD rats. In the urea cycle,
citrulline and arginine are recycled with each other and together
maintain protein homeostasis (Ginguay and De Bandt, 2019). Some
studies showed that citrulline can significantly increase the production
of IL-6(Breuillard et al., 2015) and improve insulin sensitivity and
inflammation in mice (Starkie et al., 2003). The increase in citrulline in
the FLO exposure groups may be involved in autoimmune regulation of
inflammation. Niacin is partially converted into trigonelline and its
metabolites in the body. Some studies have found that trigonelline can
inhibit the conversion of sugars into fat and exerts anti-inflammatory
and antioxidant effects in liver and kidney cells(Afifi et al., 2016;
Costa et al., 2020). In this study, the inhibition of niacin metabolism and
the decrease in trigonelline content in the FLO exposure groups may be
among the reasons for the faster weight gain and inflammation. How
ever, changes in the metabolic pathways in feces are not only affected by
the gut microbiota (Lin et al., 2015) but may also be related to the
interaction between the liver and the intestine(Delzenne et al., 2019).
Therefore, the influence of the gut microbiota that changed with by FLO
exposure during early life on host metabolism and inflammation
through the gut-liver axis is worthy of further study.
This study clarified the effects of FLO exposure during early life on
the toxicity, gut microbiota, and fecal metabolome in SD rats. However,
the effects of FLO exposure during early life on SD rats in adulthood and
the related mechanisms of the gut microbiota affecting the metabolic

pathways were still not very clear and need to be further studied.
5. Conclusion
In summary the suckling SD rats were exposed to FLO by gavage
administration for 15 consecutive days during early life, which induced
faster weight gain and obvious inflammation in the liver and intestine.
Gut microbiota analysis demonstrated that FLO exposure during early
life caused changes in the composition of the intestinal bacteria, a sig
nificant decrease in diversity, and a high abundance expression of
antibiotic resistance genes in the suckling SD rats. Analysis of the fecal
metabolome also further confirmed the influence of FLO exposure dur
ing early life on metabolic pathways related to energy intake. Thus, FLO
exposure during early life may have the potential to affect energy
metabolism, induce inflammation, and increase the risk of obesity
development by altering the establishment of the host gut microbiota.
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